Literature DB >> 2909492

Protective role of serum antibody in immunity to chlamydial genital infection.

R G Rank1, B E Batteiger.   

Abstract

Female guinea pigs were injected intraperitoneally with pooled immunoglobulin derived from animals immunized to the chlamydial agent of guinea pig inclusion conjunctivitis. Genital infections in animals receiving pooled immunoglobulin from immune animals were markedly decreased with regard to the number of inclusions detected compared with control animals. These data indicated that serum-derived antibody was able to provide a degree of protection against a chlamydial genital tract infection.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2909492      PMCID： PMC313093          DOI： 10.1128/iai.57.1.299-301.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  Immunity to chlamydial infections of the eye. 3. Presence and duration of delayed hypersensitivity to guinea pig inclusion conjuctivitis.

Authors:  R R Watson; A B MacDonald; E S Murray; F Z Modabber
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

2.  Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.

Authors:  R G Rank; H J White; A L Barron
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection.

Authors:  D E McComb; R L Nichols; D Z Semine; J R Evrard; S Alpert; V A Crockett; B Rosner; S H Zinner; W M McCormack
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

5.  Postabortal Chlamydia trachomatis salpingitis: correlating risk with antigen-specific serological responses and with neutralization.

Authors:  R C Brunham; R Peeling; I Maclean; J McDowell; K Persson; S Osser
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

6.  Immunity to chlamydial infections of the eye. V. Passive transfer of antitrachoma antibodies to owl monkeys.

Authors:  N S Orenstein; J D Mull; S E Thompson
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

7.  Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix.

Authors:  R C Brunham; C C Kuo; L Cles; K K Holmes
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Antibodies to Chlamydia trachomatis in cervicovaginal secretions: relation to serum antibodies and current chlamydial infection.

Authors:  S J Richmond; J D Milne; A L Hilton; E O Caul
Journal:  Sex Transm Dis       Date:  1980 Jan-Mar       Impact factor: 2.830

10.  Serum and tear antibodies to Chlamydia after reinfection with guinea pig inclusion conjunctivitis agent.

Authors:  R Malaty; C R Dawson; I Wong; C Lyon; J Schachter
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-12       Impact factor: 4.799
View more
  33 in total

1.  The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A.

Authors:  Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection.

Authors:  Sandra G Morrison; Richard P Morrison
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

3.  Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.

Authors:  M Johansson; K Schön; M Ward; N Lycke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.

Authors:  Z Qu; X Cheng; L M de la Maza; E M Peterson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.

Authors:  T W Cotter; Q Meng; Z L Shen; Y X Zhang; H Su; H D Caldwell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women.

Authors:  Pragya Srivastava; Rishein Gupta; Hem Chandra Jha; Rajneesh Jha; Apurb Rashmi Bhengraj; Sudha Salhan; Aruna Mittal
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

9.  Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Authors:  Anja Weinreich Olsen; Michael Theisen; Dennis Christensen; Frank Follmann; Peter Andersen
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

10.  A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Authors:  Eno E Ekong; Daniel N Okenu; Jayanti Mania-Pramanik; Qing He; Joseph U Igietseme; Godwin A Ananaba; Deborah Lyn; Carolyn Black; Francis O Eko
Journal:  FEMS Immunol Med Microbiol       Date:  2008-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.